Diluted Calcium Hydroxylapatite Carboxymethylcellulose (Radiesse) for Décolleté Wrinkles: Safety and Effectiveness in Adult Females.
Summary
In a randomized immediate-versus-delayed design with blinded assessors, diluted CaHA-CMC (Radiesse) produced a 71.2% responder rate at 24 weeks versus 6.3% in controls, with mostly mild injection-site reactions and no interference on post-treatment breast imaging. Findings support a nonpermanent injectable option for décolleté rejuvenation.
Key Findings
- Responder rate at 24 weeks was 71.2% with diluted CaHA-CMC versus 6.3% in untreated controls.
- Adverse events were predominantly transient, mild-to-moderate injection-site reactions.
- Post-treatment radiographic breast imaging showed no interference attributable to the filler.
Clinical Implications
Supports offering diluted CaHA-CMC as a nonpermanent option for moderate-to-severe décolleté wrinkles, with counseling on expected benefits, transient local reactions, and no anticipated interference with breast imaging.
Why It Matters
Provides controlled clinical evidence for décolleté filler efficacy with imaging safety reassurance, addressing a data gap in a common aesthetic concern.
Limitations
- Primary endpoint at 24 weeks limits longer-term durability assessment.
- Female-only population; total sample size not specified in the abstract.
Future Directions
Conduct longer-term, head-to-head trials versus alternative fillers and dosing strategies, with standardized imaging and patient-reported outcomes for durability and safety.
Study Information
- Study Type
- RCT
- Research Domain
- Treatment
- Evidence Level
- I - Randomized controlled trial with blinded assessors and delayed-treatment control.
- Study Design
- OTHER